Cargando…
Protease-independent control of parthanatos by HtrA2/Omi
HtrA2/Omi is a mitochondrial serine protease with ascribed pro-apoptotic as well as pro-necroptotic functions. Here, we establish that HtrA2/Omi also controls parthanatos, a third modality of regulated cell death. Deletion of HtrA2/Omi protects cells from parthanatos while reconstitution with the pr...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439076/ https://www.ncbi.nlm.nih.gov/pubmed/37594630 http://dx.doi.org/10.1007/s00018-023-04904-7 |
_version_ | 1785092862041391104 |
---|---|
author | Weiß, Jonas Heib, Michelle Korn, Thiemo Hoyer, Justus Fuchslocher Chico, Johaiber Voigt, Susann Koudelka, Tomas Tholey, Andreas Adam, Dieter |
author_facet | Weiß, Jonas Heib, Michelle Korn, Thiemo Hoyer, Justus Fuchslocher Chico, Johaiber Voigt, Susann Koudelka, Tomas Tholey, Andreas Adam, Dieter |
author_sort | Weiß, Jonas |
collection | PubMed |
description | HtrA2/Omi is a mitochondrial serine protease with ascribed pro-apoptotic as well as pro-necroptotic functions. Here, we establish that HtrA2/Omi also controls parthanatos, a third modality of regulated cell death. Deletion of HtrA2/Omi protects cells from parthanatos while reconstitution with the protease restores the parthanatic death response. The effects of HtrA2/Omi on parthanatos are specific and cannot be recapitulated by manipulating other mitochondrial proteases such as PARL, LONP1 or PMPCA. HtrA2/Omi controls parthanatos in a manner mechanistically distinct from its action in apoptosis or necroptosis, i.e., not by cleaving cytosolic IAP proteins but rather exerting its effects without exiting mitochondria, and downstream of PARP-1, the first component of the parthanatic signaling cascade. Also, previously identified or candidate substrates of HtrA2/Omi such as PDXDC1, VPS4B or moesin are not cleaved and dispensable for parthanatos, whereas DBC-1 and stathmin are cleaved, and thus represent potential parthanatic downstream mediators of HtrA2/Omi. Moreover, mass-spectrometric screening for novel parthanatic substrates of HtrA2/Omi revealed that the induction of parthanatos does not cause a substantial proteolytic cleavage or major alterations in the abundance of mitochondrial proteins. Resolving these findings, reconstitution of HtrA2/Omi-deficient cells with a catalytically inactive HtrA2/Omi mutant restored their sensitivity against parthanatos to the same level as the protease-active HtrA2/Omi protein. Additionally, an inhibitor of HtrA2/Omi’s protease activity did not confer protection against parthanatic cell death. Our results demonstrate that HtrA2/Omi controls parthanatos in a protease-independent manner, likely via novel, unanticipated functions as a scaffolding protein and an interaction with so far unknown mitochondrial proteins. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-023-04904-7. |
format | Online Article Text |
id | pubmed-10439076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-104390762023-08-20 Protease-independent control of parthanatos by HtrA2/Omi Weiß, Jonas Heib, Michelle Korn, Thiemo Hoyer, Justus Fuchslocher Chico, Johaiber Voigt, Susann Koudelka, Tomas Tholey, Andreas Adam, Dieter Cell Mol Life Sci Original Article HtrA2/Omi is a mitochondrial serine protease with ascribed pro-apoptotic as well as pro-necroptotic functions. Here, we establish that HtrA2/Omi also controls parthanatos, a third modality of regulated cell death. Deletion of HtrA2/Omi protects cells from parthanatos while reconstitution with the protease restores the parthanatic death response. The effects of HtrA2/Omi on parthanatos are specific and cannot be recapitulated by manipulating other mitochondrial proteases such as PARL, LONP1 or PMPCA. HtrA2/Omi controls parthanatos in a manner mechanistically distinct from its action in apoptosis or necroptosis, i.e., not by cleaving cytosolic IAP proteins but rather exerting its effects without exiting mitochondria, and downstream of PARP-1, the first component of the parthanatic signaling cascade. Also, previously identified or candidate substrates of HtrA2/Omi such as PDXDC1, VPS4B or moesin are not cleaved and dispensable for parthanatos, whereas DBC-1 and stathmin are cleaved, and thus represent potential parthanatic downstream mediators of HtrA2/Omi. Moreover, mass-spectrometric screening for novel parthanatic substrates of HtrA2/Omi revealed that the induction of parthanatos does not cause a substantial proteolytic cleavage or major alterations in the abundance of mitochondrial proteins. Resolving these findings, reconstitution of HtrA2/Omi-deficient cells with a catalytically inactive HtrA2/Omi mutant restored their sensitivity against parthanatos to the same level as the protease-active HtrA2/Omi protein. Additionally, an inhibitor of HtrA2/Omi’s protease activity did not confer protection against parthanatic cell death. Our results demonstrate that HtrA2/Omi controls parthanatos in a protease-independent manner, likely via novel, unanticipated functions as a scaffolding protein and an interaction with so far unknown mitochondrial proteins. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-023-04904-7. Springer International Publishing 2023-08-18 2023 /pmc/articles/PMC10439076/ /pubmed/37594630 http://dx.doi.org/10.1007/s00018-023-04904-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Weiß, Jonas Heib, Michelle Korn, Thiemo Hoyer, Justus Fuchslocher Chico, Johaiber Voigt, Susann Koudelka, Tomas Tholey, Andreas Adam, Dieter Protease-independent control of parthanatos by HtrA2/Omi |
title | Protease-independent control of parthanatos by HtrA2/Omi |
title_full | Protease-independent control of parthanatos by HtrA2/Omi |
title_fullStr | Protease-independent control of parthanatos by HtrA2/Omi |
title_full_unstemmed | Protease-independent control of parthanatos by HtrA2/Omi |
title_short | Protease-independent control of parthanatos by HtrA2/Omi |
title_sort | protease-independent control of parthanatos by htra2/omi |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439076/ https://www.ncbi.nlm.nih.gov/pubmed/37594630 http://dx.doi.org/10.1007/s00018-023-04904-7 |
work_keys_str_mv | AT weißjonas proteaseindependentcontrolofparthanatosbyhtra2omi AT heibmichelle proteaseindependentcontrolofparthanatosbyhtra2omi AT kornthiemo proteaseindependentcontrolofparthanatosbyhtra2omi AT hoyerjustus proteaseindependentcontrolofparthanatosbyhtra2omi AT fuchslocherchicojohaiber proteaseindependentcontrolofparthanatosbyhtra2omi AT voigtsusann proteaseindependentcontrolofparthanatosbyhtra2omi AT koudelkatomas proteaseindependentcontrolofparthanatosbyhtra2omi AT tholeyandreas proteaseindependentcontrolofparthanatosbyhtra2omi AT adamdieter proteaseindependentcontrolofparthanatosbyhtra2omi |